The analysis revealed no statistically significant differences between the two groups with respect to age, gender, stoma status, CA125 levels, T stage, pathological TNM stage, primary tumor location, tumor size, mismatch repair (MMR) status, Ki67 expression, and administration of postoperative chemotherapy (P>0.05). This evidence concerns the gene MKI67 and neoplasm.